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Background: Vitamin D insufficiency (serum 25-OH vitamin D > 10 ng/ml and < 30 ng/ml) is prevalent in the obese
(body mass index (BMI) > 30 kg/m2), yet relationships between the two are poorly understood. Objectives of this
study include identification of the impact of obesity on reducing serum 25-OH vitamin D concentration, particularly
in response to altered vitamin D3 supplementation, and to elucidate the longitudinal impact of serum 25-OH
vitamin D on body mass index.
Methods: Twenty four-week-old lean and obese male C57BL/6 J mice were fed low, standard, or high levels of
cholecalciferol supplementation and followed for 24 weeks. Longitudinal measurements include serum 25-OH and
1,25-(OH)2 vitamin D, intact PTH, and calcium concentrations, as well as BMI, bone density and body fat/lean mass.
Results: Baseline serum 25-OH concentrations were not different in lean and obese mice (lean 32.8 ± 4.4 ng/ml
versus obese 30.9 ± 1.6 ng/ml p = 0.09). Lean mice receiving low supplementation exhibited rapid declines in
serum 25-OH vitamin D concentrations, falling from 33.4 ± 5.4 ng/ml to 14.5 ± 3.4 ng/ml after 2 weeks, while
obese mice declined at a lower rate, falling from 30.9 ± 1.5 to 19.0 ± 0.9 ng/ml within the same time period.
Surprisingly, high vitamin D3 supplementation did not substantially increase serum vitamin D concentrations
above standard supplementation, in either lean or obese mice. No differences in serum 1,25-(OH)2 vitamin D,
intact parathyroid hormone (PTH) or serum calcium were observed between lean and obese mice within the
same vitamin D supplementation group. Yet obese mice exhibited lower serum calcitriol, higher serum PTH, and
lower bone mineral density (BMD) than did lean mice. Additionally, neither body mass index nor body fat % was
significantly correlated with vitamin D concentrations. Interestingly, lean mice with high vitamin D supplementation
consumed significantly more food than did lean mice with standard or low supplementation (14.6 ± 1.7 kcal/mouse/
day versus 11.8 ± 1.4 and 12.3 ± 1.7 respectively, p < 0.0001 for both).
Conclusions: Low cholecalciferol supplementation in both lean and obese mice significantly and sustainably reduces
serum 25-OH vitamin D concentrations. Interestingly, obesity slowed the rate of decline. Over the period of the study,
vitamin D insufficiency was not subsequently correlated with greater BMI/body fat, although lean mice with high
supplementation consumed greater calories with no apparent BMI increase.
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Table 1 Diet compositions
Component (g/kg) Low fat Diet High fat diet





Soybean oil 25 32
Lard 20 317
t-Butylhydroquinone (TBHQ) 0.005 0.006
Cellulose 50 65
Dicalcium Phosphate 13 17
Calcium Carbonate 5.5 7.1
Potassium Citrate 16.5 21.3
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Vitamin D insufficiency (serum 25-OH vitamin D
>10 ng/ml and <30 ng/ml) is a prevalent condition with
an estimated 70% of the population considered at risk
[1, 2]. Concurrent with widespread vitamin D insuffi-
ciency, the Centers for Disease Control also reports
that a large percentage of the population (>35%) has a
body mass index (BMI) considered obese. Several hu-
man studies have explored the possibility that these two
phenomena may be linked [3–6], however, it remains
unclear if vitamin D insufficiency promotes weight gain
and/or if obesity modulates serum vitamin D concen-
tration. Interestingly, studies seeking to modulate body
weight by correcting vitamin D status have been unsuc-
cessful [7–9], although other beneficial effects, includ-
ing reduced body fat [7], reduced inflammatory profile
[9], and improved insulin resistance [10] were seen.
Contrary to what is seen in human trials, animal studies
appear to show that vitamin D may promote weight
gain. Vitamin D receptor (VDR) knock-out mice were
shown to be resistant to weight gain [11, 12], as were
diet-induced vitamin D deficient/insufficient mice to
high fat [13] and “western” diets [14]. Additionally,
over-expression of VDR in adipocytes induced weight
gain in mice [15]. Although interpretation of these data
suggests that vitamin D, through VDR, increases weight
gain, other studies have shown that administration of
1,25-(OH)2 vitamin D, the active form of vitamin D and
direct ligand to VDR, decreases weight and has other
beneficial effects [16, 17].
Alternatively, data from several studies suggest obesity
may impair the effectiveness of vitamin D supplementa-
tion. Supplementation in the obese has resulted in less
than expected supplementation, [18–21] and these find-
ings are further supported by a meta-analysis of greater
than 12,000 patients showing that BMI negatively corre-
lates with the effect of supplementation [22]. Additionally,
mice given 2,000 IU vitamin D3/kg chow in a “western”
diet had similar serum 25-OH vitamin D concentration as
their lean counterparts given 1,000 IU vitamin D3/kg
chow at the conclusion of the study [14]. It has been spec-
ulated that fat sequestration of vitamin D leads to lower
serum concentrations [21], although this traditional view
has recently been challenged by one study suggesting dilu-
tion by greater body mass and not fat sequestration leads
to the dampening effects [23].
Studies examining the interrelationships between serum
vitamin D insufficiency and obesity frequently focus on
human populations where differing lifestyle and/or genetic
factors may obfuscate findings. Animal models, on the
other hand, predominately make use of receptor knock-
outs or complete dietary removal to simulate vitamin D
deficient conditions, which may not accurately reflect the
more prevalent condition of insufficiency in humans.To further explore the relationships between 25-OH
vitamin D status and weight/body fat, we induced vitamin
D insufficiency in lean and obese mice and examined food
consumption, body weight, and body composition. Our
data indicate that higher BMI modestly buffers serum 25-
OH vitamin D concentration in response to lower supple-
mentation. Further, our findings also suggest that neither
high or low vitamin D3 supplementation modulates body
weight or body fat.
Methods
Mice
All studies and experimental protocols were approved
by and in compliance with guidelines of the Miami VA
Animal Care and Use Committee. At all times mice
were provided ad libitum access to chow/water and
covered to avoid exposure to facility lighting. 8-week-
old male C57BL/6 mice were randomly assigned to
either high fat (60% FDC, Dyets Inc, Bethlehem, PA,
ID# D180988) or low fat (10% FDC, ID# D180989)
feeding for 16 weeks. Mice failing to gain more than
10% body weight were removed from the study. At
24 weeks of age, lean mice were randomly assigned to
low fat diets containing 125, 1000 or 4000 IU vitamin
D3/kg chow and obese mice to high fat diets containing
162, 1282 or 5169 IU vitamin D3/kg chow (Table 1),
and were followed for 24 additional weeks. Numbers of
animals were nine for lean-low & lean-standard, eight
for lean-high, six for obese-low & obese-standard, and
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weighed on a weekly basis. Additionally, mouse length
was measured at the end of the study by anesthetizing
mice and measuring from nose to the base of the tail.
BMI was calculated as g/cm2 [24].
Serum analysis
Blood was extracted through the sub-mandibular vein
using a mouse lancet (MEDIpoint, inc., Mineola, NY.)
and collected into microcentrifuge tubes. Samples were
held at room temperature for 10 min to allow coagula-
tion and then centrifuged at 13,000 RPM for 10 min to
allow separation of serum. Analysis of serum was per-
formed using specific ELISA kits for 25-OH vitamin D
(ImmunoDiagnostic Systems, Inc., Scottsdale, AZ), 1,25-
(OH)2 vitamin D (MyBioSource, San Diego, CA.) and in-
tact PTH (MyBioSource), while colorimetric assays were
used to assess calcium (Biovision, San Francisco, CA.)
according to manufacturer protocols.
Dual-energy X-Ray absorptiometry
Analysis of bone mineral density, body fat % and lean
mass was performed using a Lunar PIXImus II (GE
Healthcare, United Kingdom). Animals were anesthetized
and then analyzed with a single scan at baseline and every
8 weeks thereafter.
Statistics
Two-way ANOVA, followed by post hoc Tukey’s Multiple
Comparisons test when applicable, was used for compari-
sons between all vitamin D and diet groups at each time
point as well as between vitamin D groups and time
points, separately for obese and lean (Ian E. Holliday,
2012, Two-Way ANOVA (v1.0.3) in Free Statistics Soft-
ware (v1.1.23-r7), Office for Research Development and
Education, http://www.wessa.net/rwasp_Two%20Factor%
20ANOVA.wasp). An * indicates statistically significant re-
sults corresponding to * for p < 0.05, ** for p < 0.01, ***
for p < 0.001 and **** for p < 0.0001. All data were
screened for potential outliers using GraphPad onlineTable 2 Mean food and vitamin D3 consumption in mice. Lean and o




Low Lean 3.38 ± 0.4
Obese 2.82 ± 0.1
Standard Lean 3.24 ± 0.3
Obese 2.77 ± 0.1
High Lean 4.00 ± 0.4
Obese 2.94 ± 0.1software (La Jolla, CA.), using a significance cut-off of
0.05. All data are presented as mean ± standard deviation.
Results and Discussion
Serum 25-OH vitamin D concentrations fall rapidly with low
supplementation to a constant insufficient level, while
greater supplementation leads to little increase; obesity
tempers decline in response to low vitamin D chow
In order to understand the varied interrelationships be-
tween vitamin D and body weight/composition, we set
out to establish a range of serum 25-OH vitamin D con-
centrations between insufficiency (>10 ng/ml) and above
sufficiency (>30 ng/ml) in lean and obese mice. To do
so, we provided lean mice vitamin D3 supplementation
at low (125 IU/kg chow), standard for most animal fa-
cilities (1,000 IU/kg chow) and high (4,000 IU/kg chow)
amounts and in obese mice by providing low (162 IU/
kg chow), standard (1,282 IU/kg chow) and high
(5,169 IU/kg chow) amounts (Table 1). We increased
vitamin D3 supplementation for obese groups to ac-
count for the lower food consumption rate that occurs
during high fat feeding [25, 26]. As expected, we found
no statistically significant difference in the amount of
vitamin D3 being consumed between lean and obese
mouse groups (Table 2). To confirm establishment of
vitamin D insufficient and sufficient mice we measured
serum 25-OH vitamin D concentrations at baseline and
every two weeks thereafter (Fig. 1a). There was no sta-
tistically significant difference in serum 25-OH vitamin
D between lean and obese mice (lean n = 26, 32.8 ±
4.4 ng/ml versus obese n = 19, 30.9 ± 1.6 ng/ml, p = 0.09).
Similarly, Park et al. did not find differences in serum
25-OH vitamin D in obese and lean 22 week old mice,
suggesting body composition does not modulate serum
vitamin D levels during consistent supplementation [25].
We then modified cholecalciferol given in chow to eluci-
date whether body composition affects response to altered
supplementation. Mice given low supplementation experi-
enced a rapid decline evident at two weeks, with
stabilization between 11–12 ng/ml by 8 weeks, independent
of being lean or obese. The rate of decline in serum 25-OHbese mice were given ad libitum access to chow containing









7 0.42 ± 0.06 p = 1.00
9 0.46 ± 0.03
9 3.24 ± 0.39 p = 0.86
9 3.55 ± 0.25
6 15.97 ± 1.87 p = 0.057
6 15.20 ± 0.85
Fig. 1 Analysis of serum 25-OH vitamin D3 concentrations of lean and
obese mice in response to altered vitamin D3 supplementation. Serum
25-OH vitamin D3 concentration was measured every two weeks using
ELISA in lean (L) and obese (O) mice given low (125 IU/kg chow),
standard (STD, 1000 IU/kg chow) or high (4000 IU/kg chow) amounts
of vitamin D3 a Decline from baseline serum 25-OH vitamin D
concentration was further calculated for L-LOW and O-LOW b.
Symbols indicate p < 0.05 between L-HIGH and L-STD (*), L-HIGH
and O-HIGH (‡), and L-LOW and O-LOW (†)
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goats and cows [27–29], but more rapid than the reported
half-life of approximately 20 days in humans [30]. However,
the rate of decline was steeper in lean compared to obese
mice, with the decline from baseline over two weeks being
18.8 ± 5.7 ng/ml versus 11.9 ± 1.1 ng/ml (**p = 0.0084), re-
spectively (Fig. 1b). This salient observation supports the
notion that fat sequestration may buffer against the loss of
serum 25-OH vitamin D during low supplement intake.
Furthermore, serum 25-OH vitamin D was significantly
greater at several time points in low supplemented obese
mice compared to lean (week 8: *p = 0.0247, week 20: *p =
0.0410, and week 24: ***p = 0.0003, Fig. 1a), which would
not be consistent with the Drincic et al. dilution model
[23]. Yet, the overall magnitude of the differences (~1–
2 ng/ml) does not strongly support a role of fat sequestra-
tion in controlling serum 25-OH vitamin D.
Interestingly, higher supplementation failed to signifi-
cantly increase serum 25-OH vitamin D concentrations
compared to standard amounts after 24 weeks in both
lean and obese mice. Non-linear increases during supple-
mentation to raise serum vitamin D above 30 ng/ml havebeen observed in rats [31], and similar 25-OH concentra-
tions were detected in lean mice given 1000 IU/kg chow
compared to obese mice given just over 2000 IU/kg chow
[14]. Taken together, these reports and our data reflecting
a non-linear increase in supplementation between 1000–
4000 IU/kg chow are inconsistent with those of Fleet et al.
[32] demonstrating linear increases from 400 IU/kg chow
through 20,000 IU/kg chow. It is important to note that
Fleet et al. used weanling mice in and did not specifically
interrogate supplementation with 2000 or 4000 IU/kg
chow. Furthermore, our data suggest that the obese/lean
status of the mouse does not modulate the effects of
higher supplementation. These findings run contrary to
numerous human clinical trials showing diminished eleva-
tions with supplementation due to obesity [20, 21, 33, 34],
but not all [19, 35]. A possible explanation for the lack of
effect in our study was the failure of higher supplemen-
tation to increase 25-OH vitamin D levels above stand-
ard supplementation in either lean or obese mice, a
ceiling effect that may be masking potential obesity im-
pacts. Our data show that high supplemented lean mice
had significantly greater 25-OH vitamin D concentra-
tion at week 16 over obese mice (week 16, **p = 0.0040
versus high supplemented obese mice), however, as this
difference did not persist we were unable to confidently
conclude that obesity modulates the effects of higher
supplementation.Obese mice, independent of serum vitamin D status,
exhibit differences in serum 1,25-(OH)2 vitamin D and
intact PTH concentration relative to lean mice, with no
effect on serum calcium
To further identify the impacts of varied 25-OH vitamin D
levels, we analyzed the serum concentration of 1,25-(OH)2
vitamin D, intact parathyroid hormone (PTH) and calcium
(Fig. 2a-c) in lean and obese mice after 24 weeks of altered
vitamin D3 supplementation. Our findings reveal there were
no significant differences in any serum 25-OH vitamin D
levels between vitamin D groups in either lean or obese
mice. However, obese mice exhibited lower 1,25-(OH)2
vitamin D and higher intact PTH compared to lean mice
(****p < 0.0001 for both), and these findings in our mouse
model are consistent with data from a study in lean and
obese humans [36]. We did not observe statistically signifi-
cant differences in serum calcium due to obesity (p = 0.27).
Our findings for intact PTH and serum calcium in obese
and lean 48-week-old mice are in agreement with the re-
ported levels in 22-week-old obese and lean mice [25].
However, we do report a significantly lower, and Park et al.
[25] a significantly higher, serum 1,25-(OH)2 vitamin D in
obese mice relative to lean. As expected, we detected a
positive association between serum levels of 1,25-(OH)2
vitamin D and intact PTH (r2 = 0.24, **p = 0.0014, Fig. 2d).
a b





























































































1,25(OH)2 vitamin D (pmol/L)
Fig. 2 Serum profiles of lean and obese mice following supplementation
with varied amounts of Vitamin D3. Serum was collected following
24 weeks of either low, standard or high vitamin D3 supplementation,
and analyzed for serum 1,25-(OH)2 vitamin D3 a, intact PTH b and
calcium c concentration using ELISA or colorimetric assay. Correlative
analysis was further performed between serum intact PTH and serum
1,25-(OH)2 vitamin D d. Different letters denote a significant difference










































































Fig. 3 Food consumption and BMI in mice fed high or low fat diet
containing varying levels of vitamin D3. Twenty-four week old male mice
were randomly sorted into low, standard (STD) or high vitamin D3
supplementation groups and followed for 24 weeks. Body mass
index a for each mouse was determined weekly using mouse
length measurements from week 24 b. Mouse length endpoint
measurements reflect the distance from nose to the base of the
tail. Food consumption was measured weekly and group means
were averaged c. Different letters denote significant differences
(****p < 0.0001)
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ported. The nature of these conflicting data may be due to
the greater length of time of exposure to high fat diet
(48 weeks in our study versus 18 weeks for Park et al.) that
has allowed greater time for an equilibrium between PTH
and serum 1,25-(OH)2 vitamin D consistent with observa-
tions in human studies [36].
To our surprise, differing supplementation and the subse-
quent impacts on serum 25-OH vitamin D concentrations,
had no significant correlation with 1,25-(OH)2 vitamin D or
iPTH serum markers in these mice, a finding that is com-
parable to observations from a study in rats [31]. Although,
this study may have been underpowered to detect effects
on 1,25-(OH)2 vitamin D, intact PTH and calcium, this
phenomenon may also reflect the narrow dosing range de-
signed to induce insufficiency. Indeed effects on these
serum markers were reported in other studies when supple-
menting outside the normo-physiological range used in our
study of roughly 125–5,000 IU/kg chow [32, 37].
Lean mice receiving higher amounts of cholecalciferol have
higher caloric intake yet maintain similar body weight
Numerous human studies have identified negative asso-
ciations between body mass index (BMI) and serum 25-
OH vitamin D concentrations [2, 4, 6, 38], leading tospeculation that low 25-OH vitamin D may promote
weight gain and correction of vitamin D status may pro-
mote weight loss in overweight individuals. To investi-
gate the modulating effects of serum vitamin D on body
mass index, we followed body weight changes in lean
and obese mice supplemented with varying amounts of
vitamin D for 24 weeks (Fig. 3a). Our findings suggest
vitamin D insufficiency does not potentiate additional
weight gain in lean or obese mice compared with suffi-
ciency. Furthermore, no effect on BMI was observed in
highly supplemented lean or obese mice, which is
consistent with human studies that have attempted to
promote weight loss through vitamin D supplementation
[7–9, 39]. However, in our study, mice with high supple-
mentation had serum 25-OH and 1,25-(OH)2 vitamin D
concentrations similar to mice given standard amounts,
which may indicate that these mice did not receive high
enough supplementation to affect BMI. Indeed, evidence
that greater supplementation might affect BMI was
recently reported by Marcotorchino et al. [40], where
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during a high fat diet. Mice in that study were only
6 weeks of age at the start of the experiment and not
obese at baseline, yet these findings may indicate a ne-
cessary level of supplementation to see an effect.
Despite the lack of an effect of higher supplementation
on BMI or serum vitamin D metabolites, our lean mice
supplemented with 4000 IU/kg chow had greater caloric
consumption over the length of the study (14.6 ± 1.7 kcal/
mouse/day versus 11.8 ± 1.4 for 1000 IU and 12.3 ± 1.7 for
125 IU, ****p < 0.0001 for both, Fig. 3b). The inference from
these data is that the greater food consumption was offset
by higher metabolism, perhaps suggesting a weight loss
strategy involving caloric restriction might be improved by
vitamin D supplementation. Interestingly, Shapses et al.
were unable to discern an effect on weight loss in humansFig. 4 Impacts on bone mineral density and relationship with serum biomark
vitamin D on bone mineral density were analyzed using DEXA a No statistica
all lean and obese mice were significant for bone mineral density (ap = 0.004;
serum 25-OH b or 1,25-(OH)2 vitamin D c, but was correlated with serum intawith a dual vitamin D supplementation and caloric restric-
tion protocol [41]. But it is possible that the 2500 IU vita-
min D3/day supplementation strategy was not equivalent
to the higher level of supplementation in our mice.
Overall, our findings that vitamin D insufficiency had no
effect on BMI in our mice run contrary to findings by Bas-
tie et al. [14] and to a lesser extent Liu et al. [13], where diet
induced vitamin D deficient mice were resistant to “west-
ern” and high fat diet induced weight gain, respectfully.
However these studies induced vitamin D deficiency con-
currently with alterations in diet. Whereas in our study the
mice had been fed a HFD for four months prior to initi-
ation of the vitamin D intervention. Additionally we believe
the age at which mice were made insufficient/deficient may
also be an important factor. We observed that the average
length of our obese mice at 48 weeks of age wasers. The effects of high fat and low fat diet containing varying levels of
l differences observed between vitamin D groups. Differences between
bp < 0.0001; cp < 0.008). Bone mineral density was not correlated with
ct PTH (R2 = 0.32, ****p < 0.0001) d
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100.6 ± 2.3 cm, ****p < 0.0001, Fig. 3c). We found no
length differences between vitamin D groups, which
would be expected as mice have likely stopped growing by
the time supplementation was adjusted. However, both
Bastie et al. and Liu et al. varied vitamin D supplementa-
tion before 3–5 weeks of age which may have lead to nu-
merous impacts on the development of the mice not seen
in our study since variations in vitamin D supplemen-
tation occurred after maturity. Interestingly, although
our study is the first report of high fat feeding leading
to increased length in mice, several human studies
have found trends between higher BMI and height in
adolescents [42–44].
Serum 25-OH vitamin D insufficiency does not modulate
body fat, lean mass or bone mineral density in either lean
or obese mice
Vitamin D is canonically recognized as being important
for bone health, and more recently for impacts on body
fat and lean mass, yet the impacts of chronic insuffi-
ciency on these parameters have not been elucidated.
Therefore, we performed dual X-Ray absorptiometry
(DEXA) analysis at baseline and every two months
thereafter on our mouse cohorts (Figs. 4 and 5). Sur-
prisingly, despite 6 months of vitamin D insufficiency,
neither lean nor obese insufficient mice exhibited lower
BMD compared to sufficient mice (Fig. 4a). These find-
ings are in general agreement with Fleet et al. [32], with
the exception of lower BMD seen in a group receiving
25 IU vitamin D3/kg chow group, for which supplemen-
tation was below our lowest tested group. Interestingly,
high supplementation failed to increase BMD in mice as
























Fig. 5 Analysis of body composition of lean and obese mice given low, sta
and low fat diet containing varying levels of vitamin D on body fat % a an
DEXA. No statistical differences observed between vitamin D groups. Differ
(at all time points, ****p < 0.0001) and gain in lean body mass (a versus b, *of this level of supplementation to substantially increase
serum levels of 25-OH vitamin D or the possibility that
we were underpowered to observe this effect. Further-
more, we did not identify association between BMD with
either serum 25-OH vitamin D (Fig. 4b) or 1,25-(OH)2
vitamin D (Fig. 4c), but there was a negative correlation
between BMD and serum intact PTH (r2 = 0.33, ****p <
0.0001 Fig. 4d). This difference remained significant
when controlling for BMI of the mice (**p = 0.0014,
data not shown) and reflects the key role of PTH in
bone homeostasis [45].
However, obese mice exhibited lower BMD at all time
points except at baseline (0 weeks: p = 0.17; 8 weeks:
**p = 0.004; 16 weeks: ****p < 0.0001; and 24 weeks: **p =
0.008, Fig. 4a). Interestingly, in other mouse studies such
differences in total BMD between obese and lean were not
observed, yet differences in bone density were observed
when utilizing μCT [46–48]. One key distinction between
our study and the other reports is that the length of nearly
48 weeks in our study that may have provided enough
time for obesity related-effects on BMD to become mani-
fest. It is also noteworthy that higher supplementation was
not able to counteract the effects of obesity. However, as
higher supplementation did not significantly affect 25-OH
or 1,25-(OH)2 vitamin D concentration, the possibility re-
mains that supplementation beyond 4,000 IU/kg chow
may rescue obesity related bone deficits.
Our data reveal that vitamin D insufficiency does not
modulate body fat percentage (Fig. 5a) or lean tissue mass
(Fig. 5b) in lean or obese mice. Yet, we did detect a larger
gain of lean mass in obese mice versus lean mice over the
48-week period (**p = 0.002, Fig. 5b). Interestingly, no ef-
fects were seen in mice receiving higher amounts of vita-




















ndard and high vitamin D supplementation. The effects of high fat
d the gain in lean body mass over 48 weeks b were analyzed using
ences between all lean and obese mice were significant for body fat %
*p = 0.002)
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due to a differing range of supplementation levels, or that
vitamin D may have roles unique to human physiology.
Conclusions
We have established a model of vitamin D insufficiency in
lean and obese mice by reducing vitamin D3 supplementa-
tion in chow. Obese mice exhibited a slower rate of
decline in serum 25-OH vitamin D and modestly higher
levels at equilibrium. No differences in serum 1,25-(OH)2
vitamin D, intact parathyroid hormone (PTH) or serum
calcium were observed between lean and obese mice
within the same vitamin D supplementation group. Yet
obese mice exhibited lower serum calcitriol, higher serum
PTH, and lower bone mineral density (BMD) than did
lean mice. It also appears that 25-OH vitamin D concen-
trations between 10 to 40 ng/ml did not correlate with
body weight or body fat in mice, although higher supple-
mentation in mice fed a standard diet correlated with in-
creased food consumption weight or lean/fat mass. The
increase in caloric consumption without a concurrent in-
crease in energy storage implies a heightened metabolism,
which, if coupled to a calorically restricted diet may prove
to be an effective strategy for weight loss.
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